Molecular Autism

Papers
(The TQCC of Molecular Autism is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Coping, fostering resilience, and driving care innovation for autistic people and their families during the COVID-19 pandemic and beyond139
Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology123
Is social camouflaging associated with anxiety and depression in autistic adults?114
The psychological impact of the COVID-19 pandemic on adults with autism: a survey study across three countries82
Prevalence and cumulative incidence of autism spectrum disorders and the patterns of co-occurring neurodevelopmental disorders in a total population sample of 5-year-old children77
Cannabinoid treatment for autism: a proof-of-concept randomized trial66
Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study42
Gender identity, sexual orientation and adverse sexual experiences in autistic females42
Increased aperiodic gamma power in young boys with Fragile X Syndrome is associated with better language ability42
Sleep disorders in rare genetic syndromes: a meta-analysis of prevalence and profile41
Reduced auditory steady state responses in autism spectrum disorder40
Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis39
Differential mirror neuron system (MNS) activation during action observation with and without social-emotional components in autism: a meta-analysis of neuroimaging studies39
Exploring the mechanisms underlying excitation/inhibition imbalance in human iPSC-derived models of ASD39
Towards robust and replicable sex differences in the intrinsic brain function of autism37
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis36
Cerebral organoids as tools to identify the developmental roots of autism33
Development and validation of the suicidal behaviours questionnaire - autism spectrum conditions in a community sample of autistic, possibly autistic and non-autistic adults32
Dissecting the phenotypic heterogeneity in sensory features in autism spectrum disorder: a factor mixture modelling approach32
Inattention and hyperactive/impulsive component scores do not differentiate between autism spectrum disorder and attention-deficit/hyperactivity disorder in a clinical sample31
Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder30
Beyond the three-chamber test: toward a multimodal and objective assessment of social behavior in rodents30
Targeting the RHOA pathway improves learning and memory in adult Kctd13 and 16p11.2 deletion mouse models30
Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse model29
Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mouse model of autism Shank3B28
White matter alterations in autism spectrum disorder and attention-deficit/hyperactivity disorder in relation to sensory profile28
Imitation and recognition of facial emotions in autism: a computer vision approach28
Physical health of autistic girls and women: a scoping review28
Sex differences in the first impressions made by girls and boys with autism27
Evidence for the placenta-brain axis: multi-omic kernel aggregation predicts intellectual and social impairment in children born extremely preterm26
Pharmacological intervention to restore connectivity deficits of neuronal networks derived from ASD patient iPSC with a TSC2 mutation26
The Autism Biomarkers Consortium for Clinical Trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials26
Common and unique multimodal covarying patterns in autism spectrum disorder subtypes26
Developmental changes in attention to social information from childhood to adolescence in autism spectrum disorders: a comparative study26
Targeting PPARα in the rat valproic acid model of autism: focus on social motivational impairment and sex-related differences25
An investigation of the diet, exercise, sleep, BMI, and health outcomes of autistic adults25
The Comprehensive Autistic Trait Inventory (CATI): development and validation of a new measure of autistic traits in the general population25
Face individual identity recognition: a potential endophenotype in autism24
Examining a stepped-care telehealth program for parents of young children with autism: a proof-of-concept trial24
Transcriptional signatures of participant-derived neural progenitor cells and neurons implicate altered Wnt signaling in Phelan-McDermid syndrome and autism24
Gray matter covariations and core symptoms of autism: the EU-AIMS Longitudinal European Autism Project23
Elevated de novo protein synthesis in FMRP-deficient human neurons and its correction by metformin treatment23
Modified CBT for social anxiety and social functioning in young adults with autism spectrum disorder23
Prospective and detailed behavioral phenotyping in DDX3X syndrome22
Identification of amygdala-expressed genes associated with autism spectrum disorder22
Differentially altered social dominance- and cooperative-like behaviors in Shank2- and Shank3-mutant mice21
Tsc1 haploinsufficiency in Nkx2.1 cells upregulates hippocampal interneuron mTORC1 activity, impairs pyramidal cell synaptic inhibition, and alters contextual fear discrimination and spatial working m21
Exploring sensory phenotypes in autism spectrum disorder21
Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome21
Dysregulation of protein synthesis and dendritic spine morphogenesis in ASD: studies in human pluripotent stem cells21
Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder21
Neuroanatomy and behavior in mice with a haploinsufficiency of AT-rich interactive domain 1B (ARID1B) throughout development20
Autistic adults have poorer quality healthcare and worse health based on self-report data20
Advanced paternal age as a risk factor for neurodevelopmental disorders: a translational study20
Globally elevated excitation–inhibition ratio in children with autism spectrum disorder and below-average intelligence20
Resting state EEG power spectrum and functional connectivity in autism: a cross-sectional analysis20
Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction20
High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons20
How rare and common risk variation jointly affect liability for autism spectrum disorder19
Fever during pregnancy as a risk factor for neurodevelopmental disorders: results from a systematic review and meta-analysis19
Human in vitro models for understanding mechanisms of autism spectrum disorder19
IGF-1 treatment causes unique transcriptional response in neurons from individuals with idiopathic autism19
Deep phenotyping reveals movement phenotypes in mouse neurodevelopmental models18
De novo missense variants disrupting protein–protein interactions affect risk for autism through gene co-expression and protein networks in neuronal cell types18
Improving the measurement of alexithymia in autistic adults: a psychometric investigation of the 20-item Toronto Alexithymia Scale and generation of a general alexithymia factor score using item respo18
Autism symptoms in anorexia nervosa: a comparative study with females with autism spectrum disorder18
Chd8 haploinsufficiency impairs early brain development and protein homeostasis later in life18
Left hemispheric deficit in the sustained neuromagnetic response to periodic click trains in children with ASD18
0.061725854873657